文献速递头颈部肿瘤放疗

鼻咽癌调强放疗与二维放疗后放射相关第二原发恶性肿瘤的风险及预后生存分析

Risk and prognostic survival analysis of radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma: intensity-modulated radiotherapy and two-dimensional radiotherapy.
PubMed 文献 · Radiother Oncol · 2026-09-13

本研究比较调强放疗(IMRT)与历史二维放疗(2D-RT)鼻咽癌幸存者中第二原发恶性肿瘤(SMN)的长期风险与预后。IMRT队列8,032例、2D-RT队列39,118例,IMRT队列粗发生比例为3.49%、2D-RT为0.63%,中位潜伏期分别为7.3年和9.5年;IMRT队列多因素分析显示男性、年龄≤50岁和吸烟史为独立危险因素。发生SMN者5年总生存IMRT队列为38.6%、2D-RT队列为29.3%。

要点

  • IMRT队列SMN粗发生比例3.49%,高于2D-RT队列的0.63%。
  • IMRT队列5年、10年、15年竞争风险累积发生率分别为1.15%、3.09%、6.66%。
  • 男性、年龄≤50岁、吸烟史为IMRT队列SMN独立危险因素。

核心结论

  • IMRT队列放射相关SMN的观察粗发生率数值上高于历史2D-RT队列,且潜伏期更短。
  • 男性、较年轻年龄和吸烟史是IMRT队列SMN发生的独立危险因素。
  • 发生SMN的患者中,IMRT队列观察到的总生存估计高于2D-RT队列。

研究设计与样本

  • 跨时代机构研究,IMRT±化疗队列8,032例,历史2D-RT±化疗队列39,118例,均为初诊非转移性鼻咽癌患者。
  • IMRT队列SMN危险因素采用单因素和多因素Cox比例风险模型评估。
  • 生存结局采用Kaplan-Meier法评估。

主要发现

  • IMRT队列212例、2D-RT队列247例发生放射相关SMN,观察粗比例分别为3.49%和0.63%。
  • IMRT队列5年、10年、15年竞争风险累积发生率分别为1.15%、3.09%、6.66%。
  • SMN诊断中位潜伏期IMRT队列为7.3年,2D-RT队列为9.5年。
  • 口腔和鼻腔鼻窦区域为常见SMN部位,鳞状细胞癌为主要组织学类型。
  • 发生SMN者5年总生存IMRT队列为38.6%,2D-RT队列为29.3%。

关键数值与推荐

  • IMRT队列多因素Cox分析中,男性、年龄≤50岁和吸烟史与SMN发生独立相关。

临床怎么用

  • 对鼻咽癌IMRT幸存者,尤其男性、年龄≤50岁和吸烟史者,应关注SMN长期监测。
  • 随访中需注意口腔和鼻腔鼻窦区域及鳞状细胞癌组织学类型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: To clarify the long-term risk and prognostic implications of second malignant neoplasms (SMNs) among nasopharyngeal carcinoma survivors in intensity-modulated radiotherapy (IMRT) and historical two-dimensional radiotherapy (2D-RT) cohorts. MATERIALS AND METHODS: We extracted data from 8,032 and 39,118 initially diagnosed, non-metastatic NPC patients treated with IMRT ± chemotherapy and 2D-RT ± chemotherapy, respectively. Risk factors for SMN development in the IMRT cohort were evaluated using univariate and multivariable Cox proportional hazards models. Survival outcomes were assessed using the Kaplan-Meier method. RESULTS: Radiation-related SMNs occurred in 212 patients in the IMRT cohort and 247 patients in the historical 2D-RT cohort, corresponding to observed crude proportions of 3.49% and 0.63%, respectively. In the IMRT cohort, the 5-, 10-, and 15-year competing-risk cumulative incidences were 1.15%, 3.09%, and 6.66%, respectively. Median latency to SMN diagnosis was 7.3 years in the IMRT cohort and 9.5 years in the historical 2D-RT cohort. The oral cavity and sinonasal region were common SMN sites, and squamous cell carcinoma was the predominant histology. In multivariable Cox analysis within the IMRT cohort, male sex, age ≤ 50 years, and smoking history were independently associated with SMN development. Among patients with SMNs, 5-year overall survival was 38.6% in the IMRT cohort and 29.3% in the historical 2D-RT cohort. CONCLUSIONS: In this cross-era institutional study, the IMRT cohort showed a numerically higher observed crude incidence and shorter latency of radiation-related SMNs than the historical 2D-RT cohort. Male sex, younger age, and smoking history were independent risk factors for SMN development. Among patients who developed SMNs, observed overall survival estimates were higher in the IMRT cohort.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Huang R, Lou J, Li C, et al. Risk and prognostic survival analysis of radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma: intensity-modulated radiotherapy and two-dimensional radiotherapy. Radiother Oncol. 2026. PMID: 42732821. doi:10.1016/j.radonc.2026.111776

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。